Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Phosphatidylcholine Deactivates Cytotoxic CD8+ T Cells through Ufmylation Mediated By Exosomal SerpinB9 in Multiple Myeloma

Huihan Wang, Xue SHI, Zimu Gong

Blood (2024) 144 (Supplement 1): 5403.

https://doi.org/10.1182/blood-2024-193111

Published: 2024

Journal Articles

The Influence of Measurable Residual Disease and Post-Remission Treatment to the Prognosis of ALL

Peipei Li, Xue Sun, Xue Shi, Xiaoqian Liu, Yujie Jiang, Xiaohui Sui, Xiaosheng Fang

Blood (2024) 144 (Supplement 1): 5935.

https://doi.org/10.1182/blood-2024-199545

Published: 2024

Journal Articles

Real-World Effectiveness and Safety Analysis of Carfilzomib-Pomalidomide- Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Multicenter Retrospective Study from Eastern Shandong of China

Huishou Fan, Rongxia Wei, Xiangyan Feng, Xin Zhang, Tianlan Li, Lu Liu, Hui Wang, Lingjie Sun, Xue Shi, Hongguo Zhao, Zhao Li, Jingying Cui, Xianqi Feng, Junqing Xu, Junjie Ma, Lugui Qiu, Wei Wang

Blood (2024) 144 (Supplement 1): 7032.

https://doi.org/10.1182/blood-2024-207159

Published: 2024

Journal Articles

Effect of MRD Level after Induction Therapy and Post-Remission Treatment on Prognosis of ALL Patients

Xue Sun, Xiaosheng Fang, Xiaoqian Liu, Ying Li, Xue Shi, Yahan Li, Ran Tan, Yujie Jiang, Xiaohui Sui, Xueling Ge, Hongzhi Xu, Xin Wang

Blood (2022) 140 (Supplement 1): 11850–11851.

https://doi.org/10.1182/blood-2022-168452

Published: 2022

Journal Articles

Novel Fusion Genes Involving Hnrnpc and Rarg in Acute Myeloid Leukemia Mimicking Acute Promyelocytic Leukemia

Zhan Su, MD, Xin Liu, MD PhD, Yan Xu, MD, Weiyu Hu, MD, Chunting Zhao, MD, Hongguo Zhao, MD, Xianqi Feng, MD, Shuchao Zhang, Jie Yang, Xue Shi, Lugui Qiu, MD PhD, Jun Peng, MD PhD

Blood (2018) 132 (Supplement 1): 5274.

https://doi.org/10.1182/blood-2018-99-111433

Published: 2018

NARROW

Phosphatidylcholine Deactivates Cytotoxic CD8+ T Cells through Ufmylation Mediated By Exosomal SerpinB9 in Multiple Myeloma

The Influence of Measurable Residual Disease and Post-Remission Treatment to the Prognosis of ALL

Real-World Effectiveness and Safety Analysis of Carfilzomib-Pomalidomide- Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Multicenter Retrospective Study from Eastern Shandong of China

Effect of MRD Level after Induction Therapy and Post-Remission Treatment on Prognosis of ALL Patients

Novel Fusion Genes Involving Hnrnpc and Rarg in Acute Myeloid Leukemia Mimicking Acute Promyelocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Phosphatidylcholine Deactivates Cytotoxic CD8+ T Cells through Ufmylation Mediated By Exosomal SerpinB9 in Multiple Myeloma

The Influence of Measurable Residual Disease and Post-Remission Treatment to the Prognosis of ALL

Real-World Effectiveness and Safety Analysis of Carfilzomib-Pomalidomide- Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Multicenter Retrospective Study from Eastern Shandong of China

Effect of MRD Level after Induction Therapy and Post-Remission Treatment on Prognosis of ALL Patients

Novel Fusion Genes Involving Hnrnpc and Rarg in Acute Myeloid Leukemia Mimicking Acute Promyelocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only